Cargando…
The potential benefits of low-molecular-weight heparins in cancer patients
Cancer patients are at increased risk of venous thromboembolism due to a range of factors directly related to their disease and its treatment. Given the high incidence of post-surgical venous thromboembolism in cancer patients and the poor outcomes associated with its development, thromboprophylaxis...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830957/ https://www.ncbi.nlm.nih.gov/pubmed/20074349 http://dx.doi.org/10.1186/1756-8722-3-3 |